BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 703989)

  • 1. A comparative study between radioreceptor assay and radioimmunoassay for hCG in patients with trophoblastic disease.
    Kletzky OA; Scott JZ; Morrow CP; Mishell DR
    Obstet Gynecol; 1978 Sep; 52(3):328-31. PubMed ID: 703989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL; Russell HT
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and clinical application of the quantitative radioreceptor assay for serum hCG.
    Boyko WL; Russell HT
    Obstet Gynecol; 1979 Dec; 54(6):737-45. PubMed ID: 514561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the heterogeneity of urinary HCG molecules by RRA and RIA (author's transl)].
    Kushiki N; Fuzishima K; Kinoshita T; Ino H; Naka O
    Nihon Naibunpi Gakkai Zasshi; 1979 Sep; 55(9):1076-88. PubMed ID: 227758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantitative use of Biocept-G radioreceptorassay.
    Hussa RO; Mattingly RF
    Obstet Gynecol; 1979 Aug; 54(2):199-204. PubMed ID: 460754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T; Matsuura S; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay].
    Matsuura Y; Kashimura M; Shinohara M; Baba S; Kondo M; Kashimura Y
    Gan No Rinsho; 1990 Dec; 36(15):2559-62. PubMed ID: 2176247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioimmunologic and radioreceptor analysis of human chorionic gonadotropin for the diagnosis and control of ectopic pregnancy].
    Conte N; Testa D; Barbero P; Diani F
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):977-81. PubMed ID: 7126372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of rapid radioimmunoassay for urinary beta-human chorionic gonadotropin (beta hCG-RIA) in early pregnancy.
    Xu RQ; Li YY; Zhou SZ; Fei RT; Liu YH
    Acta Acad Med Wuhan; 1984; 4(2):105-8. PubMed ID: 6204259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological and biochemical properties of human chorionic gonadotropin from urine of patients with hydatidiform mole and its radioimmunoassay (author's transl)].
    Nishimura R; Hamamoto T; Tanabe K; Takemori M; Ashitaka Y; Tojo S
    Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1632-44. PubMed ID: 7327293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter.
    Tomoda Y; Asai Y; Arii Y; Kaseki S; Nishi H; Miwa T; Saiki N; Ishizuka N
    Cancer; 1977 Sep; 40(3):1016-25. PubMed ID: 198083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of pregnancy with a radioreceptor assay for hCG.
    Roy S; Klein TA; Scott JZ; Kletzky OA; Mishell DR
    Obstet Gynecol; 1977 Oct; 50(4):401-6. PubMed ID: 904801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.